Gimv
Covagen extends series-B with Baxter investment
Swiss biotech Covagen has extended its CHF 42m series-B funding round, raised in December, to procure a further CHF 2.9m from Baxter Ventures.
German PE tempted by allure of Luxembourg LPs
With a government promising to keep industry regulation fine-tuned to the benefit of its denizens, Luxembourg has become a hotspot for GPs in post-AIFMD Europe. Ellie Pullen reports
Gimv and Alsace acquire Wolf in SBO
Gimv and Alsace Capital have acquired French designer and manufacturer of women’s underwear Wolf Group from Cathay Capital and EPF Partners.
Gimv and Cube to acquire VTB
Gimv and the Cube Infrastructure Fund are to wholly acquire Veolia Transport Belgium (VTB), the Belgian operations of France-headquartered Transdev Group.
Gimv partially exits Punch Powertrain
Gimv has divested 30% of its stake in Punch Powertrain, a Belgian manufacturer of auto parts, to Chinese private equity house New Horizon Capital.
Gimv et al. invest CHF 42m in Covagen
Swiss biotech business Covagen has secured CHF 42m for its series-B funding round from a consortium of venture capital firms led by Gimv.
Gimv backs Eurocept
Gimv has invested in Eurocept Group, a Dutch provider of medical homecare services and specialised medicines, in exchange for a minority stake.
Gimv, UI Gestion acquire Almaviva
Gimv and UI Gestion have acquired French operator of private clinics Almaviva Santé from 21 Partners, with each of the firms contributing €40m towards the buyout.
Gimv commits further capital to DG Infra
Infrastructure-focused investor DG Infra has secured additional financing from its sponsors, Gimv and Belfius Bank, with a plan to invest up to €400m over the next five years.
Gimv leads €8.5m round for Itineris
Gimv and PMV have invested €8.5m in Belgian software company Itineris, alongside the company’s founder and CEO.
Bencis to take Xeikon private
Bencis Capital Partners has made a mandatory public offer to acquire all issued shares of Xeikon for €5.85 per share, giving the company an enterprise value of €168m.
Hard times over for hardware investments?
The hardware end of Europe’s technology market has largely been ignored by GPs in favour of the safety net of software. Ellie Pullen investigates the reasons behind its neglect and whether the sector is about to become a more appealing investment opportunity
Gimv fully exits Ablynx
Gimv has sold its remaining direct stake of 2.24% in Euronext-listed Ablynx, a Belgian biotechnology company, for €19.1m.
NovoPolymers pulls in further VC funding
Gimv, Capricorn Venture Partners and the Federale Participatie- en Investeringsmaatschappij (SFPI-FPIM) have reinvested in Belgian solar encapsulant manufacturer NovoPolymers alongside new backer Capital-E.
Sector focus: An outbreak of biotech IPOs
Biotech IPOs
St Jude Medical acquires PE-backed Endosense
Medical device company St Jude Medical has wholly acquired Endosense, a medical technology company backed by several private equity firms, for CHF 159m.
Benelux exit market lifts
Benelux
Gimv et al. back Jenavalve
A consortium of venture capital investors has injected $62.5m as part of a series-C round for Jenavalve Technology, a Germany-based medical devices manufacturer.
Gimv and Bencis pinch Punch's Xeikon
Gimv and Bencis Capital Partners have acquired a stake in listed Dutch printing business Xeikon from parent company Punch International.
VC-backed Prosensa raises $78m in IPO
Dutch biotechnology company Prosensa Holding, which is backed by a consortium of venture capital firms, has listed on the Nasdaq Global Select Market in an IPO valuing the business at $408m.
Gimv and EdRip back Complix with €12m
Gimv and Edmond de Rothschild Investment Partners (EdRip) have led a €12m series-B round for Belgian biopharmaceutical company Complix.
Gimv backs MBO of Luciad
Gimv has acquired a majority stake in Luciad, a Belgian supplier of situational awareness systems-building software, alongside the company’s management.
Gimv and Iris invest €15m in Alven-backed Planetveo
Gimv and Iris Capital have invested €15m in French online travel agency Planetveo, which has previously received backing from Alven Capital.
Gimv backs €40m investment in Lampiris
Gimv has jointly invested €40m in Belgian green energy supplier Lampiris with the Regional Investment Company of Wallonia (SRIW).